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Editor's key points
The diagnosis of malignant hyperthermia relies on the functional analysis of in vitro muscle contracture testing, and shows unexplained phenotypic variability. The clinical features and cellular calcium signalling properties in muscle biopsies of patients seen in a Canadian malignant hyperthermia testing centre were analysed. Patients testing positive to halothane only in the caffeineehalothane contracture test showed more marked clinical features and calcium signalling abnormalities, consistent with a distinct diagnostic group. The pathophysiological mechanism and clinical implications of these findings require further study.
Malignant hyperthermia (MH 1, 2 ; MIM# 145600) is a potentially fatal disorder of excitationecontraction (EC) coupling, a couplonopathy, 3 with underlying alterations of the Ca 2þ transients that couple action potentials and contractile activation. MH susceptibility (MHS) is usually associated with mutations in RYR1, which encodes the Ca 2þ release channel of the sarcoplasmic reticulum (SR). 4, 5 Mutations in the CACNA1S 4 and Stac3 genes 6, 7 are also associated with MHS. There are several conditions associated with MHS that can hamper the diagnosis and management. 11 For example, exertional heat stroke 12 and exertional rhabdomyolysis 13, 14 associate with the same MH-linked variants. 2, 15 The phenotypic variability can lead to additional primary diagnoses, as in 30% of patients with central core disease and 49% of patients with familial idiopathic hyperCKaemia, who are also diagnosed as MH susceptible. 13, 15, 16 The caffeineehalothane contracture test (CHCT) or in vitro contracture test, which has high sensitivity for the diagnosis of MHS, is performed on at-risk individuals who lack a known causative mutation. The present study focuses on a group of MH-susceptible patients, called 'HH', who reacted normally to caffeine, but were positive to halothane in the CHCT. We address primarily the HH group because we observed more muscle symptoms and signs in the absence of anaesthesia in our cohort compared with other MH-susceptible patients. Because caffeine and halothane enhance SR Ca 2þ release by different mechanisms, 17e20 the halothane sensitivity of the HH suggests a specific pathogenesis. Whilst HH patients are MH susceptible, we hypothesise that unique pathophysiological features separate them from the conventional MH-susceptible patients. To test the hypothesis, we undertook the systematic monitoring of Ca 2þ signals of EC coupling in biopsied muscle cell fragments and in myotubes derived from every biopsy.
Methods

Ethical approval
After approval by the institutional Research Ethics Board of Toronto General Hospital, informed consents were obtained from all patients who underwent CHCT. The consent included sharing of anonymised genomic data for research purposes. The use of biopsies for cell cultures and functional study was approved by the Institutional Review Board of Rush University.
Patients
Our criteria for CHCT included a previous adverse anaesthetic reaction, family history of MH, repeated exercise-or heatinduced rhabdomyolysis, or idiopathic increased serum creatine kinase (hyperCKaemia) and negative genetic testing for MH-causative mutations. Additionally, patients who carried a variant of unknown significance in RYR1 or CACNA1S underwent CHCT. Amongst 121 patients enrolled, 22 had no family or personal history of MH events (detailed in Supplementary  Table S3 ).
Caffeineehalothane contracture test
Susceptibility to MH was diagnosed based on the North American CHCT protocol. 21 Contractile forces (F C and F H ) were measured on freshly excised muscle bundles with initial twitch responses that met the viability criteria. Bundles were exposed successively to 0.5, 1, 2, 4, 8, and 32 mM caffeine or to halothane 3%. The threshold responses for a positive diagnosis were F H (in halothane 3%) !0.7 g and F C (in 2 mM caffeine) !0.3. Testing was performed on at least three muscle fascicles per agent; the largest force in each trial determined the diagnosis. Patients were 'MH negative' if the force was below the threshold for both agonists, and 'MH susceptible' if at least one of the exposures exceeded the threshold. We labelled those positive to halothane only as 'HH' and those positive for both agonists as 'HS'.
Molecular genetics
RNA was isolated from blood or muscle, and cDNA synthesis and PCR amplification of the RYR1 and CACNA1S transcripts were performed as published. 22e24 Alternatively, using genomic DNA from blood, we amplified and sequenced the coding regions of all exons plus 20e100 flanking bases in RYR1. Sequences were compared with the RYR1 reference (NM_00540.2 and NC_000019.9) and variants were validated using bioinformatics. To determine whether an unidentified variant segregated with the disease, first-and second-degree relatives were genotyped by Sanger sequencing.
Clinical index
Features related to skeletal muscle involvement were used to compile a clinical index. These included five components: weakness and fatigability (s 1 ), pain and cramps (s 2 ), sensitivity to heat or exercise (s 3 ), CKaemia (s 4 ), and histopathology (s 5 ). Based on severity, each was assigned scores between 0 and 2 (normal, mild changes, and severe changes). 'Clinical index' was defined as the equal-weight average of these components, rescaled to the range 0e10. Further details and example provided in Supplementary Table S3 .
Cell-level procedures
Biopsied segments of gracilis muscle were shipped to Rush University at 4 C overnight in sterile DMEM-F12 (Gibco, Grand Island, NY, USA) containing antibioticeantimycotic 1%. Cultures, produced as in Censier and colleagues, 25 were maintained at 37 C in a humid atmosphere containing CO 2 5%. After 8e15 days, cells derived from the explants were transferred in a growth medium to a culture dish for proliferation. Myoblasts were expanded through up to four passages. For optical measurements, myoblasts were reseeded on collagen-coated dishes (MatTek, Ashland, MA, USA). At 70% confluence, the cells were switched to a differentiation medium (DMEM-F12 with horse serum 2.5%). Studies were carried out 5e10 days thereafter in myotubes showing a similar degree of maturation. Myoblasts were made from excess biopsied muscle to develop to myotubes or frozen for further propagation. The derivation of cultures was successful in 95 (of 121) patients. Viable myotubes were obtained in up to four passages. The present study used first and second passage cultures. ] cyto as described. 28 
Cytosolic calcium measurements
Calcium index
Four measurements, represented as x j , j¼1e4, were made in 20e40 myotubes of multiple cultures from each patient:
Caffeine-halothane contracture test and clinical index. A, contractile force of muscle strips in response to 2 mM caffeine vs. force in response to 3 vol% halothane. B, same data in logarithmic scales. Results in the blue region are "normal"; patients qualify as HN. The HS region maps forces excessive ("positive") for both caffeine and halothane. Tests in region labeled HH had discrepant results, positive for halothane but not caffeine. No patients had the reciprocal results (the HC region was empty). The correlation between forces induced by caffeine and halothane was high (r 2 ¼ 0.73). In both panels the short dashed line represents equal forces in response to both agonists. F H in HS were generally much greater than in HH. C, Clinical Index, plotted vs. F C and F H . The highest values of the index are found in HH patients. The index averages were significantly higher than in HN but the difference between HH and HS was not significant (statistics in Supplemental Table 1 ). Special symbols identify patients with pathogenic mutations (Supplemental Table 2 ). In B, the abscissae have a small random number added (À0.018 > r < 0.018, smaller than the precision of the measurement) to reduce overlap and provide a better visual depiction of numbers of patients.
resting [Ca 2þ ] cyto (x 1 ), fraction of myotubes having spontaneous Ca 2þ sparks or macro-sparks (x 2 ), fractions having propagated Ca 2þ waves (x 3 ), and cell-wide Ca 2þ spikes after electrical stimulation (x 4 ). The bin boundaries were chosen so that the x j in the reference cells (HN) was close to 0, whilst the values from the HS and HH spanned the 0e3 range. The calcium index is the average of the x j , rescaled to the 0e10 range. Cell-level measurements were performed in 16 patients of each CHCT group.
Solutions
The composition (in mM) of Krebs solution was NaCl 145, KCl 5, CaCl 2 2.6, MgCl 2 1, HEPES 10, and glucose 5.6. For dye loading, cell cultures were in Krebs with 5 mM of indo-1 AM or fluo-4 AM for 35 min at 37 C. The solutions were adjusted to pH 7.2 and 300e320 mOsmol kg
À1
. The experiments were carried out at 20 C.
Statistics
When distributions satisfied normality tests, averages were compared parametrically; otherwise, properties were compared by non-parametric tests of differences of medians. Measured cell-level variables were subject to principal component analysis (PCA), 29, 30 as described in Supplementary methods.
Results
Between January 2013 and December 2017, 121 patients undergoing CHCT at the Malignant Hyperthermia Investigation Unit (Canada) were recruited for this study: 59 (49%) were normal (HN), 21 (17%) were hypersensitive to halothane and caffeine (HS), and 41 (34%) were hypersensitive to halothane only (HH). The mean ages were 37.1, 34.4, and 36.8 yr. 39%, 51%, and 48% of the patients in HN, HS, and HH groups, respectively,were males.
Caffeineehalothane contracture test Figure 1 shows the relationship between the force generated in response to halothane or caffeine, F H and F C , assessed for all patients. The two thresholds divide the space of results in four regions. F H was on average greatest in the region of doubly positive results, HS. Forces were positively correlated (r 2 ¼0.73), but had a remarkable asymmetry: whilst in many patients, F H was above the threshold and F C was not, the reverse was never true. Given that MHS is diagnosed by hypersensitivity to one or both agonists, the caffeine component of the test was not relevant to MHS diagnosis in this cohort. The caffeine test instead allowed for the definition of the HH, a group comprising approximately one-third of these patients, with positive response for halothane only.
Clinical index
In Figure 1c , every patient is represented by a symbol at coordinates F C , F H , and clinical index. The plot shows that the highest values of clinical index were found in the HH group. The index average was highest in the HH group, but its difference from the HS group is not statistically significant (Supplementary Table S1 ). A personal or family history of adverse anaesthetic events did not associate with significant differences in clinical index.
Cell-level studies
The first cell-level measure, resting [Ca 2þ ] cyto , showed a clear increase in HH and HS myotubes ( Table 1 ). The second measure was frequency of spontaneous Ca 2þ release, which in myotubes appeared as Ca 2þ sparks, 'macro-sparks' or waves (Fig 2) . Such events were essentially absent in HN myotubes. The other measures quantified the response to an electrical stimulus. That of a normal myotube (Fig 3a) was a fast increase in [Ca 2þ ] cyto usually spanning the whole cell as a result of a brief homogeneous cell-wide release flux (Fig 3b) . Trains of stimuli activated HN cells synchronously and Ca 2þ release terminated immediately after the train (Fig 3c) . HH and HS myotubes instead featured moderately frequent Ca 2þ waves and spikes after an electrical stimulation. a completed study. The averages for both the HS and HH groups are significantly greater than for the HN group. As for the clinical index, the average calcium index was highest for the HH group, but in this case, the difference with the HS group was significant (Table 1) . When compared separately, three of the index components were significantly higher in the HH than the HN group; the fourth was also higher, but the difference was not statistically significant. Two of the components were significantly higher in the HS than the HN group.
The calcium index is plotted vs the clinical index in Fig 5b, 
Multivariate statistical analysis
Calcium index is simply the equal-weight average of scores of four measurements, chosen by their practicality in a large cohort and the assumption that they would reveal distinct relevant aspects of the condition. Recognising some arbitrariness in the procedure, we used PCA as a more objective method (detailed in Supplementary Material). PCA is independent of all clinical knowledge, CHCT included, and transforms the original data ([Ca   2þ ] cyto and three frequencies,
represented as x j ) into four 'principal components', c j . It does so linearly by multiplying the x j by four sets of four coefficients, one set per component. The components are numbered in decreasing order of their variances, which represent their likely relevance for group separation. The coefficients are listed in Table 2 , together with the variances of the respective components. Thus, Component 1 is calculated as
and Component 2 by a similar combination using the coefficients in column 2. A cross plot of the first two principal components is shown in Fig 5c. The HH patients are unequivocally separated from the other groups by principal components. Variances 1 and 2 together amount to~90% of the sum of all four variances. This implies that Components 3 and 4 contribute little to the separation of groups; therefore, little is gained by examining these variables. The centres of mass of the three groups (stars in Fig 5c) are close to horizontal, indicating that Component 1 accounts for most of the inter-group variance (the one relevant for classification), whilst that of Component 2 has a large intra-group contribution. The dashed line is the ideal boundary between the normal and altered results according to this analysis. It leaves all but two of the HH on the 'abnormal side', in contrast with the HS individuals who fall mostly on the 'normal side' of the line.
Genetic analysis
The results of genetic screening are summarised in Supplementary Table S2 . The HH group had no single unifying genetic feature. Only 12% carried RYR1 variants, all of which are of unknown significance.
Discussion
That all positive MH diagnoses by CHCT of 121 patients were based on an excess F H implies that the contribution of the caffeine challenge to the diagnosis of MHS was nil in this group. Instead, the absence of reaction to caffeine singled out a group of patients (HH group) who, according to our summary clinical index, were more symptomatic than those hyperreactive to both agonists (HS group). The observation was surprising, given that F C , the force in reaction to halothane, was, in most HS muscles and on average, greater than in the HH group. The HH group was heterogeneous. Genetic variants in RYR1 and CACNA1S were present in a minority of HH patients, which indicates that this phenotype was not due in general to mutations in these genes, which is consistent with recent reports of difficulties in predicting the pathogenicity of variants The dashed line is a tentative border, placed by eye, between a region of normal cell-level phenotype and one of abnormal phenotype. While most HS patients lie on the "normal" side of the line, all but two of the HH patients occupy the "abnormal" region. Two HH outliers are identified by patient ID # next to the symbol. Crosses within symbols identify patients with no personal or family MH history, present in every group. ] cyto , which will increase the basal activation of RyR and modify its properties in less direct ways. The other measured endpoints, waves and spikes, contribute to principal Components 1 and 2 with small or negative weights, which implies that they do not favour either diagnostic group. Delayed waves and spikes remain opaque in mechanism and significance.
Given the known limitations of work with myotubes, the present measures must be taken as indicators of probable functional properties of the developed myofibre. The patients were heterogeneous in disease aetiology and staging; therefore, group characteristics (e.g. the high value of Component 1 in the HH group) cannot substitute for a detailed study of individual patients.
In conclusion, HH patients are considered MH susceptible; however, they differ from patients with positive responses to both caffeine and halothane in having significant cell-level alterations, manifested in high resting [ 
